Report overview
The global Cardiovascular Drug-Eluting Stents(DES) market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Passive Coating Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Cardiovascular Drug-Eluting Stents(DES) include MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin and Terumo Medical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Drug-eluting stents can also be called drug-releasing stents. Drugs are carried by polymers coated on the surface of metal stents. Released to the cardiovascular wall tissue to exert biological effects
This report aims to provide a comprehensive presentation of the global market for Cardiovascular Drug-Eluting Stents(DES), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular Drug-Eluting Stents(DES). This report contains market size and forecasts of Cardiovascular Drug-Eluting Stents(DES) in global, including the following market information:
Global Cardiovascular Drug-Eluting Stents(DES) Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Cardiovascular Drug-Eluting Stents(DES) Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Cardiovascular Drug-Eluting Stents(DES) companies in 2023 (%)
We surveyed the Cardiovascular Drug-Eluting Stents(DES) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiovascular Drug-Eluting Stents(DES) Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Cardiovascular Drug-Eluting Stents(DES) Market Segment Percentages, by Type, 2023 (%)
Passive Coating
Active Coating
Global Cardiovascular Drug-Eluting Stents(DES) Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Cardiovascular Drug-Eluting Stents(DES) Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Global Cardiovascular Drug-Eluting Stents(DES) Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Cardiovascular Drug-Eluting Stents(DES) Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiovascular Drug-Eluting Stents(DES) revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Cardiovascular Drug-Eluting Stents(DES) revenues share in global market, 2023 (%)
Key companies Cardiovascular Drug-Eluting Stents(DES) sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Cardiovascular Drug-Eluting Stents(DES) sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Boston Scientific
MicroPort Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cardiovascular Drug-Eluting Stents(DES), market overview.
Chapter 2: Global Cardiovascular Drug-Eluting Stents(DES) market size in revenue and volume.
Chapter 3: Detailed analysis of Cardiovascular Drug-Eluting Stents(DES) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiovascular Drug-Eluting Stents(DES) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cardiovascular Drug-Eluting Stents(DES) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
